Assignee
GENEQUANTUM HEALTHCARE SUZHOU CO LTD
CN·17 granted patents·18 pending applications·32 citations·filing 2015–2025
Top patents by PatentIndex Score
35 records- 0196US12012582B2Conjugation device and method for producing conjugatesGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 18, 2024·4 cites·20 claims
- 0295US11578297B2Conjugation device and method for producing conjugatesGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Feb 14, 2023·8 cites·20 claims
- 0394US11453870B2Ligase fusion proteins and application thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2021·Granted Sep 27, 2022·7 cites·5 claims
- 0492US11834688B2Ligase fusion proteins and application thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Dec 5, 2023·2 cites·28 claims
- 0591US11999748B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 4, 2024·1 cites·17 claims
- 0690US11814394B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 14, 2023·1 cites·7 claims
- 0789US11040084B2Stable antibody-drug conjugate, preparation method therefor, and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2015·Granted Jun 22, 2021·6 cites·18 claims
- 0888US12428616B2Conjugation device and method for producing conjugatesGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2024·Granted Sep 30, 2025·0 cites·19 claims
- 0987US11826432B2Linkers, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 28, 2023·2 cites·26 claims
- 1087US11717576B2Antibody-immune agonist conjugate and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Aug 8, 2023·1 cites·23 claims
- 1182US2024156894A1Stable antibody-drug conjugate, preparation method therefor, and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1282US2024165192A1Stable antibody-drug conjugate, preparation method therefor, and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1375US12467103B2Ligase fusion proteins and application thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 11, 2025·0 cites·12 claims
- 1472US12485299B2Antibody-immune agonist conjugate and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 1572US11911434B2Stable antibody-drug conjugate, preparation method therefor, and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2021·Granted Feb 27, 2024·0 cites·8 claims
- 1672US2025064957A1Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1771US11911435B2Stable antibody-drug conjugate, preparation method therefor, and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 1870US12318457B2Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·10 claims
- 1965US12377151B2Immobilized endoglycosidase fusion protein and use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2024·Granted Aug 5, 2025·0 cites·17 claims
- 2065US2025312477A1Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 2165US2024066141A1Linkers, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2265US2025312476A1Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 2363US2025312470A1A pharmaceutical composition of anti-her2 antibody-immune agonist conjugate and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2462US12539336B2Antibody, linkers, payload, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 2562US2025213484A1A freeze-drying process for an adcGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2662US2026053940A1Pharmaceutical composition of antibody drug conjugateGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2761US2025043005A1Antibody-cytokine fusion proteins and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2860US2021187114A1Novel linker, preparation method, and application thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 2958US2026077056A1Linker-payload compound, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3056US2025387505A1Anti-fgfr3 antibody conjugate and medical use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3156US2024181072A1Anti-HER2 Antibody-Immune Agonist Conjugate and Applications ThereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3253US2023338568A1Novel isomeric compounds comprising a ring-opened thiosuccinimide group, an oligopeptide fragment and a chiral moietyGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 3351US2023256108A1A drug conjugate and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 3451US2023101266A1Anti-trop2 antibodies, antibody-drug conjugates, and application of the sameGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 3550US2021221907A1Antibodies specific to trophoblast antigen 2 (trop2)GENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENEQUANTUM HEALTHCARE SUZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →